Aurinia Pharmaceuticals Inc Stock Performance
as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
$12.53$12.9
2.19%
Downside
0.70%
Upside
52 Week's Low
52 Week's High
$6.55$12.8748.87%
Downside
0.47%
Upside
Aurinia Pharmaceuticals Inc share price movements today
- Previous Close
- $12.74
- Open
- $12.73
- Volume
- 1.1M
- Day's Low - High
- $12.53 - $12.9
- 52 Week Low - High
- $6.55 - $12.87
Aurinia Pharmaceuticals Inc Historical Returns
- 1 Month Return
- + 3.83 %
- 3 Month Return
- + 55.75 %
- 1 Year Return
- + 81.22 %
- 3 Year Return
- + 68.07 %
- 5 Year Return
- -14.55 %
Aurinia Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Aurinia Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
0.6483
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
30.67%
PE Ratio (TTM)
29.63
Industry PE ratio
-3.8535542168674697
P/B Ratio
29.6279
PEG Ratio
0EBITDA
82.6M
Revenue (TTM)
260.1M
Profit Margin
23.31%
Return On Equity TTM
17.33%
Aurinia Pharmaceuticals Inc Stock Valuation
Track how Aurinia Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Aurinia Pharmaceuticals Inc in the last 5 years
Lowest (18.64x)
June 30, 2025
Industry (-3.85x)
September 15, 2025
Today (29.63x)
September 15, 2025
Highest (90.66x)
December 31, 2024
Today’s Price to Earnings Ratio: 29.63x
Aurinia Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurinia Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.7B | -14.55% | 29.63 | 23.31% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Aurinia Pharmaceuticals Inc Stock including INR - Dollar returns
The Aurinia Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aurinia Pharmaceuticals Inc investment value today
Current value as on today
₹1,87,204
Returns
₹87,204
(+87.2%)
Returns from Aurinia Pharmaceuticals Inc Stock
₹82,219 (+82.22%)
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Aurinia Pharmaceuticals Inc Stock
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Aurinia Pharmaceuticals Inc. Average target price of $11.71
Aurinia Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Aurinia Pharmaceuticals Inc.
What analysts predicted
-9.39%DOWNSIDE
Target Price
$11.71
Current Price
$12.81
Analyzed by
13 Analysts
Target
$11.71
Aurinia Pharmaceuticals Inc target price $11.71, a slight downside of -9.39% compared to current price of $12.81. According to 13 analysts rating.
Aurinia Pharmaceuticals Inc Stock's Interest Amongst Investors
Search interest for Aurinia Pharmaceuticals Inc Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:40% versus previous 30 day period
Aurinia Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Aurinia Pharmaceuticals Inc
Insights on Aurinia Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, AUPH has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 59.86M → 70.00M (in $), with an average increase of 7.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, AUPH stock has moved up by 57.4%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 41.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 23.34M → 21.51M (in $), with an average decrease of 7.8% per quarter
About Aurinia Pharmaceuticals Inc
| Organisation | Aurinia Pharmaceuticals Inc |
| Headquarters | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
| Industry | Health Technology |
| CEO | Mr. Peter S. Greenleaf M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Aurinia Pharmaceuticals Inc
Name | Title |
|---|---|
Ms. Andrea Levin Christopher | Executive Director of Corporate Communications & Investor Relations |
Dr. Premchandran Ramiya Ph.D. | Senior Vice President of Manufacturing & Supply Chain |
Mr. Peter S. Greenleaf M.B.A. | President, CEO & Director |
Mr. Joseph M. Miller CPA | Chief Financial Officer |
Mr. Matthew Maxwell Donley M.B.A. | Chief Operations Officer |
Mr. Stephen P. Robertson | Executive VP, General Counsel, Corporate Secretary & Chief Compliance Officer |
Dr. Gregory F. Keenan M.D. | Chief Medical Officer |
FAQs
What is Aurinia Pharmaceuticals Inc share price today?
Aurinia Pharmaceuticals Inc share price today is $12.81 as on at the close of the market. Aurinia Pharmaceuticals Inc share today touched a day high of $12.9 and a low of $12.53.
What is the 52 week high and 52 week low for Aurinia Pharmaceuticals Inc share?
Aurinia Pharmaceuticals Inc share touched a 52 week high of $12.87 on and a 52 week low of $6.55 on . Aurinia Pharmaceuticals Inc stock price today i.e. is closed at $12.81,which is 0.47% down from its 52 week high and 95.57% up from its 52 week low.
What is Aurinia Pharmaceuticals Inc's market capitalisation today?
Aurinia Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Aurinia Pharmaceuticals Inc Stock (AUPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aurinia Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aurinia Pharmaceuticals Inc Shares that will get you 0.1171 shares as per Aurinia Pharmaceuticals Inc share price of $12.81 per share as on September 16, 2025 at 1:29 am IST.
What is the minimum amount required to buy Aurinia Pharmaceuticals Inc Stock (AUPH) from India?
Indian investors can start investing in Aurinia Pharmaceuticals Inc (AUPH) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Aurinia Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aurinia Pharmaceuticals Inc share’s latest price of $12.81 as on September 16, 2025 at 1:29 am IST, you will get 0.7806 shares of Aurinia Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Aurinia Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Aurinia Pharmaceuticals Inc stock has given -14.55% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?